BackGenerate Biomedicines Overview

Generate Biomedicines Long Term Debt

Generate Biomedicines's long-term debt is $51M.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$51.31M

Peer average / median

Loading

Generate Biomedicines Long Term Debt History

Loading

Generate Biomedicines vs. peers: Long Term Debt Comparison

Loading

Generate Biomedicines Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Generate Biomedicines (GENB) FAQ

As of the most recent data (March 2026), GENB shows a long-term debt of $51M. Scroll down for historical charts and peer comparison views.

Tracking GENB's long-term debt over time shows whether Generate Biomedicines is scaling, shrinking, or reshaping that part of the business. The current reading is $51M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Generate Biomedicines's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $51M) with ownership activity and broader fundamentals.